Highlights
NASDAQ: KALA       Kala Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
4.81   +0.07 (1.48%)  4.75 - 5.09  875,400

Overview

 
Avg Volume (4 weeks):292,886
4 Weeks Range:3.52 - 5.09
4 Weeks Price Volatility (%):
82.17%
52 Weeks Range:3.24 - 9.25
52 Weeks Price Volatility (%):
26.12%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kala Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company's MPPs are selectively-sized nanoparticles and have proprietary coatings. It has applied the MPP technology to create nanosuspensions of loteprednol etabonate, or LE, a corticosteroid designed for ocular applications, resulting in two product candidates in Phase 3 clinical development, KPI-121 1.0% for the treatment of inflammation and pain following ocular surgery and KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers